Health · State Street Investment Management · NYSE
HealthETF
State Street SPDR S&P Biotech ETF (XBI) is an exchange-traded fund in the Health category. It has $11.40B in assets, an expense ratio of 0.35% and a 0.35% dividend yield. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Assets under management
$11.40B
Expense ratio
0.35%
Category
Health
Dividend yield
0.35%
NAV
$156.72
Fund family
State Street Investment Management
Exchange
NYSE
Top holdings
The largest positions State Street SPDR S&P Biotech ETF reports, by weight.